Details for 2022753953

Up to date per 02.04.2026

Actions

Title / Product Name

AFICAMTEN-DOSIERUNGSREGIME ZUR BEHANDLUNG DER OBSTRUKTIVEN HYPERTROPHISCHEN KARDIOMYOPATHIE

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2022753953

EP Publication Number

4370116

E-Number

1759404

Language

PCT Number

US22073808

Publication Date

22.05.2024 A

15.01.2025 B1

Registration Date

15.01.2025

AT Publication Date

15.02.2025

Application Date

15.07.2022

Registration Number

Priorities

16.07.2021

202163203333 P

14.01.2022

202263299753 P

01.02.2022

202263305609 P

14.04.2022

202263331197 P

19.05.2022

202263343975 P

IPC

A61K 31/4245 20060101AFI20230120BHEP

Maximum Duration of Protection

15.07.2042

Owner

Cytokinetics, Inc.350 Oyster Point Blvd South San Francisco CA 94080US

Representative

No representatives present

Inventor

MALIK, Fady San Francisco, California 94080US

KUPFER, Stuart San Francisco, California 94080US

HEITNER, Stephen B. San Francisco, California 94080US

ROBERTSON, Laura Ann San Francisco, California 94080US

MENG, Lixin San Francisco, California 94080US

OSMUKHINA, Anna San Francisco, California 94080US

WOHLTMAN, Qi San Francisco, California 94080US

Information about Fees